Although it was not possible to develop a biomarker panel from serum proteins that could distinguish all the four asthma phenotypes, important proteins could significantly distinguish some phenotypes, as FCN3 was detected in different levels between eosinophilic and neutrophilic asthma. This evidence concerns the gene FCN3 and asthma.